JANX
Janux Therapeutics, Inc. NASDAQ Listed Jun 11, 2021$14.54
After hrs
$13.97
-1.45%
Mkt Cap $884.5M
52w Low $12.12
10.4% of range
52w High $35.34
50d MA $14.34
200d MA $19.58
P/E (TTM)
-7.8x
EV/EBITDA
-7.4x
P/B
0.9x
Debt/Equity
0.0x
ROE
-11.9%
P/FCF
-10.3x
RSI (14)
—
ATR (14)
—
Beta
2.81
50d MA
$14.34
200d MA
$19.58
Avg Volume
1.1M
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. In addition, its EGFR-TRACTr is designed to target EGFR in many cancer types with multiple approved monoclonal antibodies. The company was incorporated in 2017 and is headquartered in La Jolla, California.
11099 North Torrey Pines Road · San Diego, CA 92037 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | -0.65 | -0.51 | +21.5% | 13.80 | -1.6% | -1.4% | -2.8% | -2.6% | +4.0% | +1.2% | — |
| Nov 6, 2025 | AMC | -0.60 | -0.39 | +35.0% | 28.66 | +1.7% | -7.6% | -3.7% | +0.7% | -0.5% | -4.2% | — |
| Aug 7, 2025 | AMC | -0.48 | -0.55 | -14.6% | 22.58 | -1.5% | +1.1% | +0.4% | +7.5% | +10.5% | +10.6% | — |
| May 8, 2025 | AMC | -0.43 | -0.38 | +11.6% | 26.37 | -0.5% | -3.1% | -1.2% | -3.9% | -14.2% | -11.8% | — |
| Feb 27, 2025 | AMC | -0.49 | -0.36 | +26.5% | 32.01 | +1.1% | +2.7% | -0.6% | -6.3% | -1.6% | -3.9% | — |
| Nov 6, 2024 | AMC | -0.37 | -0.51 | -37.8% | 54.89 | +1.9% | -1.2% | -1.8% | -2.2% | -3.7% | -5.3% | — |
| Aug 7, 2024 | AMC | -0.32 | -0.11 | +65.6% | 35.29 | +1.1% | +3.4% | +1.6% | +3.7% | +8.0% | +13.8% | — |
| May 7, 2024 | AMC | -0.35 | -0.30 | +14.3% | 61.50 | -12.7% | -10.0% | -15.5% | -20.5% | -18.7% | -22.1% | — |
| Mar 8, 2024 | AMC | -0.37 | -0.25 | +32.4% | 39.81 | +5.5% | +0.4% | -2.5% | +0.3% | -5.1% | -0.9% | — |
| Nov 7, 2023 | AMC | -0.46 | -0.25 | +45.7% | 6.56 | +2.3% | +0.9% | -10.8% | -7.9% | +8.1% | +27.0% | — |
| Aug 8, 2023 | AMC | -0.52 | -0.42 | +19.2% | 11.87 | +0.8% | +6.8% | +6.1% | +6.0% | +5.6% | +1.1% | — |
| May 9, 2023 | AMC | -0.49 | -0.42 | +14.3% | 13.32 | +1.6% | +4.1% | -2.3% | -4.3% | -9.7% | -13.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 | Jones Trading | Maintains | Buy → Buy | — | $15.23 | $15.12 | -0.7% | -4.8% | -7.4% | -5.6% | -5.8% | -5.3% |
| Apr 20 | Barclays | Downgrade | Overweight → Underweight | — | $15.82 | $14.93 | -5.6% | +0.3% | -2.3% | -2.7% | -4.0% | -5.1% |
| Apr 15 | UBS | Downgrade | Buy → Neutral | — | $15.24 | $14.68 | -3.7% | -1.3% | -0.3% | +3.8% | +4.1% | +1.4% |
| Feb 27 | Guggenheim | Maintains | Buy → Buy | — | $13.80 | $13.58 | -1.6% | -1.4% | -2.8% | -2.6% | +4.0% | +1.2% |
| Feb 27 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $13.80 | $13.58 | -1.6% | -1.4% | -2.8% | -2.6% | +4.0% | +1.2% |
| Jan 20 | Clear Street | Downgrade | Buy → Hold | — | $13.76 | $13.11 | -4.7% | -4.4% | -3.6% | +10.0% | +7.6% | +6.4% |
| Jan 16 | Piper Sandler | Maintains | Overweight → Overweight | — | $13.72 | $13.67 | -0.4% | +0.3% | -4.2% | -3.3% | +10.3% | +7.9% |
| Dec 17 | Barclays | Maintains | Overweight → Overweight | — | $14.65 | $14.61 | -0.3% | -3.8% | -4.2% | -5.9% | -3.8% | -3.6% |
| Dec 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $33.99 | $18.51 | -45.5% | -53.3% | -49.7% | -51.8% | -51.4% | -51.2% |
| Dec 2 | BofA Securities | Maintains | Buy → Buy | — | $33.99 | $18.51 | -45.5% | -53.3% | -49.7% | -51.8% | -51.4% | -51.2% |
| Dec 2 | Stifel | Maintains | Buy → Buy | — | $33.99 | $18.51 | -45.5% | -53.3% | -49.7% | -51.8% | -51.4% | -51.2% |
| Dec 2 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $33.99 | $18.51 | -45.5% | -53.3% | -49.7% | -51.8% | -51.4% | -51.2% |
| Dec 2 | Clear Street | Maintains | Buy → Buy | — | $33.99 | $18.51 | -45.5% | -53.3% | -49.7% | -51.8% | -51.4% | -51.2% |
| Nov 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $31.53 | $32.19 | +2.1% | +10.2% | +10.0% | +8.1% | +7.8% | -49.7% |
| Nov 7 | Barclays | Maintains | Overweight → Overweight | — | $28.66 | $29.14 | +1.7% | -7.6% | -3.7% | +0.7% | -0.5% | -4.2% |
| Mar 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $32.89 | $32.53 | -1.1% | -3.2% | -8.8% | -4.2% | -6.5% | -6.8% |
| Feb 28 | Scotiabank | Maintains | Sector Perform → Sector Perform | — | $32.01 | $32.37 | +1.1% | +2.7% | -0.6% | -6.3% | -1.6% | -3.9% |
| Dec 11 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $62.36 | $62.44 | +0.1% | +1.7% | -1.4% | -2.0% | -1.3% | -4.4% |
| Dec 4 | Scotiabank | Maintains | Sector Perform → Sector Perform | — | $59.86 | $60.00 | +0.2% | +11.6% | +10.8% | +8.6% | +3.0% | +4.2% |
| Dec 3 | Stifel | Maintains | Buy → Buy | — | $40.18 | $67.17 | +67.2% | +49.0% | +66.3% | +65.0% | +61.7% | +53.4% |
| Dec 3 | Leerink Partners | Maintains | Outperform → Outperform | — | $40.18 | $67.17 | +67.2% | +49.0% | +66.3% | +65.0% | +61.7% | +53.4% |
| Dec 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $40.18 | $67.17 | +67.2% | +49.0% | +66.3% | +65.0% | +61.7% | +53.4% |
| Nov 7 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $54.89 | $55.91 | +1.9% | -1.2% | -1.8% | -2.2% | -3.7% | -5.3% |
| Nov 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $54.89 | $55.91 | +1.9% | -1.2% | -1.8% | -2.2% | -3.7% | -5.3% |
| Sep 16 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $50.01 | $50.39 | +0.8% | -0.2% | -1.1% | -3.4% | -0.1% | +0.4% |
| Aug 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $41.32 | $41.22 | -0.2% | +5.1% | +8.7% | +8.7% | +7.0% | +11.1% |
| Aug 9 | Scotiabank | Maintains | Sector Perform → Sector Perform | — | $36.49 | $36.19 | -0.8% | -1.7% | +0.3% | +4.4% | +10.1% | +13.8% |
| Aug 8 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $35.29 | $35.68 | +1.1% | +3.4% | +1.6% | +3.7% | +8.0% | +13.8% |
| Aug 8 | Wedbush | Maintains | Outperform → Outperform | — | $35.29 | $35.68 | +1.1% | +3.4% | +1.6% | +3.7% | +8.0% | +13.8% |
| May 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $48.92 | $50.00 | +2.2% | +2.2% | -2.1% | -2.9% | -2.9% | -3.7% |
| May 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $55.37 | $54.00 | -2.5% | -6.2% | -11.6% | -9.7% | -13.5% | -14.2% |
| May 8 | Wedbush | Maintains | Outperform → Outperform | — | $61.50 | $53.68 | -12.7% | -10.0% | -15.5% | -20.5% | -18.7% | -22.1% |
| Mar 13 | BofA Securities | Maintains | Buy → Buy | — | $38.83 | $39.45 | +1.6% | +2.8% | -2.7% | +1.6% | -0.1% | -0.5% |
| Mar 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $39.81 | $41.98 | +5.5% | +0.4% | -2.5% | +0.3% | -5.1% | -0.9% |
| Feb 27 | Wedbush | Maintains | Outperform → Outperform | — | $15.10 | $35.79 | +137.0% | +229.5% | +208.6% | +220.4% | +215.7% | +182.2% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.04 | $6.04 | +0.0% | +17.4% | +37.9% | +45.4% | +46.0% | +43.7% |
| Nov 8 | Wedbush | Maintains | Outperform → Outperform | — | $6.56 | $6.71 | +2.3% | +0.9% | -10.8% | -7.9% | +8.1% | +27.0% |
| Aug 10 | Wedbush | Maintains | Outperform → Outperform | — | $12.68 | $12.74 | +0.5% | -0.7% | -0.8% | -1.2% | -5.4% | -11.8% |
| Aug 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.87 | $11.96 | +0.8% | +6.8% | +6.1% | +6.0% | +5.6% | +1.1% |
| Jul 18 | Wedbush | Maintains | Outperform → Outperform | — | $12.12 | $12.12 | +0.0% | +3.1% | +4.7% | +2.9% | +5.5% | +12.5% |
| Jul 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.12 | $12.12 | +0.0% | +3.1% | +4.7% | +2.9% | +5.5% | +12.5% |
| May 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.32 | $13.53 | +1.6% | +4.1% | -2.3% | -4.3% | -9.7% | -13.4% |
| May 10 | Wedbush | Maintains | Outperform → Outperform | — | $13.32 | $13.53 | +1.6% | +4.1% | -2.3% | -4.3% | -9.7% | -13.4% |
| Apr 6 | Wedbush | Maintains | Outperform → Outperform | — | $12.20 | $12.35 | +1.2% | +10.0% | +10.7% | +14.0% | +15.2% | +22.8% |
| Mar 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.09 | $14.09 | +0.0% | -2.3% | +1.9% | -4.5% | -6.0% | -15.3% |
| Nov 14 | William Blair | Maintains | Outperform → Outperform | — | $17.93 | $17.93 | +0.0% | -8.3% | -8.1% | -12.4% | -11.9% | -18.8% |
| Jul 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $25.40 | $25.50 | +0.4% | +2.7% | +7.5% | +5.7% | +9.4% | +5.0% |
| Jul 6 | Cowen & Co. | Maintains | Outperform → Outperform | — | $25.40 | $25.50 | +0.4% | +2.7% | +7.5% | +5.7% | +9.4% | +5.0% |
| Jul 6 | BofA Securities | Maintains | Buy → Buy | — | $25.40 | $25.50 | +0.4% | +2.7% | +7.5% | +5.7% | +9.4% | +5.0% |
No insider trades available.
Data updated apr 25, 2026 4:39pm
· Source: massive.com